Cleared Traditional

Medi Lift PLUS (K220198) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220198 · Ya-Man, Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
520d
Days
Class 2
Risk

K220198 is an FDA 510(k) clearance for the Medi Lift PLUS. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Ya-Man, Ltd. (Koto-Ku, JP). The FDA issued a Cleared decision on June 28, 2023 after a review of 520 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Ya-Man, Ltd. devices

Submission Details

510(k) Number K220198 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 24, 2022
Decision Date June 28, 2023
Days to Decision 520 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
372d slower than avg
Panel avg: 148d · This submission: 520d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K220198.
Beagank 4T Plus
K233010 · Belega, Inc. · Nov 2023
C.C. Life 21
K230459 · 21 Equipment S.R.L. · Oct 2023
BTL-785BNF Handpiece
K232172 · BTL Industries, Inc. · Sep 2023
PureLift Pro Edition
K230506 · Xtreem Pulse · Jun 2023
Myolift QT
K213078 · Johari Digital Healthcare Limited · Apr 2023
PureLift Pro Plus
K221443 · Xtreem Pulse, LLC · Oct 2022